Citation Impact
Citing Papers
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C
2011 StandoutNobel
Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liver
1998
Thiazolidinediones
2004 Standout
Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset
1989
Proteins of rat serum IV. Time-course of acute-phase protein expression and its modulation by indomethacine
1999
ApoE Promotes the Proteolytic Degradation of Aβ
2008
Angiopoietin-like protein 4: health effects, modulating agents and structure–function relationships
2012
Biochemistry and pathophysiology of intravascular and intracellular lipolysis
2013
Enhanced angiogenesis in obesity and in response to PPARγ activators through adipocyte VEGF and ANGPTL4 production
2008
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
1995 Standout
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
1998 StandoutNature
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
The Role of Angiopoietin-Like Proteins in Angiogenesis and Metabolism
2008
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice
2011 StandoutNobel
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study
2012
Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation
2000
Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels
2012
Liver X receptors as integrators of metabolic and inflammatory signaling
2006
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
The Fasting-induced Adipose Factor/Angiopoietin-like Protein 4 Is Physically Associated with Lipoproteins and Governs Plasma Lipid Levels and Adiposity
2005
cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor
1993
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
1990 StandoutNature
Proteomics: quantitative and physical mapping of cellular proteins
1999
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
PRDM16 controls a brown fat/skeletal muscle switch
2008 StandoutNature
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
1998 StandoutNature
Ligand Specificity of Brain Lipid-binding Protein
1996
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Direct Binding of Activated c-Src to the β3-Adrenergic Receptor Is Required for MAP Kinase Activation
2000 StandoutNobel
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
1998 Standout
Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences
1999
Liver tumor promotion: Effect of phenobarbital on EGF and protein kinase C signal transduction and transforming growth factor-?1 expression
1991
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
1998 StandoutNature
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
2005 StandoutNature
Update on strategies to increase HDL quantity and function
2009
Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643
1997
Potent Prostaglandin A1 Analogs That Suppress Tumor Cell Growth through Induction of p21 and Reduction of Cyclin E
1998 StandoutNobel
Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
1998 Standout
Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial
2012
Lipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer's disease
2008
Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs
1997
Differential induction and regulation of peroxisomal enzymes: Predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens
1989
Peroxisome proliferator-activated receptor agonists
1997
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
2004 StandoutNature
What We Talk About When We Talk About Fat
2014 Standout
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
1995 Standout
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
2004 Standout
Effects of Rexinoids on Glucose Transport and Insulin-mediated Signaling in Skeletal Muscles of Diabetic (db/db) Mice
2004
The Human Plasma Proteome
2002 Standout
The RXR heterodimers and orphan receptors
1995 Standout
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms
2003
HDL as a target in the treatment of atherosclerotic cardiovascular disease
2005
Peroxisome proliferator-activated receptors: finding the orphan a home
1994
Proteomics to study genes and genomes
2000 StandoutNature
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
1994 Standout
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
Roles of PPARs in health and disease
2000 StandoutNature
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
Nuclear Receptors and Lipid Physiology: Opening the X-Files
2001 StandoutScience
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
2003 Standout
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS: A Nuclear Receptor Signaling Pathway in Lipid Physiology
1996
Mass spectrometry-based proteomics
2003 StandoutNature
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
LXRS AND FXR: The Yin and Yang of Cholesterol and Fat Metabolism
2005
Angiopoietin-like 4: a decade of research
2011
Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness
2006
Liver Regeneration
1997 StandoutScience
Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
1997 Standout
Protein Structure Prediction and Structural Genomics
2001 StandoutScienceNobel
INTRACELLULAR LIPID-BINDING PROTEINS AND THEIR GENES
1997
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard to Humans?
1998
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
1999 Standout
Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.
1994
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue
2016 StandoutNobel
Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors α- and γ-mediated gene expression via liver fatty acid binding protein: A signaling path to the nucleus
2001
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Chemical Glycoproteomics
2016 StandoutNobel
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
2006 StandoutScience
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Mass Spectrometry and Protein Analysis
2006 StandoutScience
Chemical Implications for Antitumor and Antiviral Prostaglandins: Reaction of Δ7-Prostaglandin A1 and Prostaglandin A1 Methyl Esters with Thiols
1997 StandoutNobel
Works of Patrick I. Eacho being referenced
Ligand-dependent interaction of hepatic fatty acid-binding protein with the nucleus
2000
Coadministration of a Liver X Receptor Agonist and a Peroxisome Proliferator Activator Receptor-α Agonist in Mice: Effects of Nuclear Receptor Interplay on High-Density Lipoprotein and Triglyceride Metabolism in Vivo
2004
Induction of Peroxisomal β-Oxidation by Nonsteroidal Anti-inflammatory Drugs
1993
A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes
2004
SHORT COMMUNICATION: Comparison of 5-bromo-2-deoxyuridine and [3H]thymidine for studies of hepatocellular proliferation in rodents
1989
A Chemical Switch Regulates Fibrate Specificity for Peroxisome Proliferator-activated Receptor α (PPARα) VersusLiver X Receptor
2003
Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis
2007
Effect of ciprofibrate, bezafibrate, and LY171883 on peroxisomal β-oxidation in cultured rat, dog, and rhesus monkey hepatocytes
1990
Common Structural Requirements for Peroxisome Proliferation by Tetrazole and Carboxylic Acid‐Containing Compounds
1996
Liver X Receptors (LXRs) Regulate Apolipoprotein AIV-Implications of the Antiatherosclerotic Effect of LXR Agonists
2004
Antidiabetic Action of a Liver X Receptor Agonist Mediated By Inhibition of Hepatic Gluconeogenesis
2003
Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883
1991
Phospholipid Transfer Protein Is Regulated by Liver X Receptors in Vivo
2002
The Effects of Peroxisome Proliferators on Protein Abundances in Mouse Liver
1996
Changes in hepatic lipid metabolism associated with lipid accumulation and its reversal in rats given the peroxisome proliferator LY171883
1990
Effect of the peroxisome proliferator LY171883 on triglyceride accumulation in rats fed a fat-free diet
1991
Niacin mediates lipolysis in adipose tissue through its G-protein coupled receptor HM74A
2005
Enlargement of High Density Lipoprotein in Mice via Liver X Receptor Activation Requires Apolipoprotein E and Is Abolished by Cholesteryl Ester Transfer Protein Expression
2003
Transgenic Angiopoietin-Like (Angptl)4 Overexpression and Targeted Disruption of Angptl4 and Angptl3: Regulation of Triglyceride Metabolism
2005
Effects of LY295427, a Low-Density Lipoprotein (LDL) Receptor Up-Regulator, on LDL Receptor Gene Transcription and Cholesterol Metabolism in Normal and Hypercholesterolemic Hamsters
1999
Inhibition of hepatic fatty acid oxidation at carnitine palmitoyltransferase I by the peroxisome proliferator 2-hydroxy-3-propyl-4-[6-(tetrazol-5-yl) hexyloxy]acetophenone
1988
Hepatic peroxisomal changes induced by a tetrazole-substituted akoxyacetophenone in rats and comparison with other species
1986
Interaction of LY171883 and other peroxisome proliferators with fatty-acid-binding protein isolated from rat liver
1991